These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 10084816

  • 1. The adverse influence of pretransplant interferon-alpha (IFN-alpha) on transplant outcome after marrow transplantation for chronic phrase chronic myelogenous leukemia increases with the duration of IFN-alpha exposure.
    Beelen DW, Elmaagacli AH, Schaefer UW.
    Blood; 1999 Mar 01; 93(5):1779-10. PubMed ID: 10084816
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase.
    Morton AJ, Gooley T, Hansen JA, Appelbaum FR, Bruemmer B, Bjerke JW, Clift R, Martin PJ, Petersdorf EW, Sanders JE, Storb R, Sullivan KM, Woolfrey A, Anasetti C.
    Blood; 1998 Jul 15; 92(2):394-401. PubMed ID: 9657736
    [Abstract] [Full Text] [Related]

  • 4. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.
    Beksac M, Celebi H, Sargín D, Yalcin A, Topcuoglu P, Kalayoglu-Besisik S, Beyan C, Arslan O, Ozcan M, Gurman G, Ilhan O, Akan H.
    Bone Marrow Transplant; 2003 May 15; 31(10):897-904. PubMed ID: 12748666
    [Abstract] [Full Text] [Related]

  • 5. [Effect of interferon-alpha on the prognosis of bone marrow transplantation in chronic myeloid leukemia].
    Xu L, Guo N, Huang X.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Nov 15; 22(11):589-91. PubMed ID: 11855148
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K, Minami S, Ueda T, Nishimura M, Tsubaki K, Takemoto Y, Takeshita A, Sao H, Kageyama S, Ueda R, Ohno R.
    Int J Hematol; 2000 Aug 15; 72(2):229-36. PubMed ID: 11039674
    [Abstract] [Full Text] [Related]

  • 8. Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry.
    Giralt S, Szydlo R, Goldman JM, Veum-Stone J, Biggs JC, Herzig RH, Klein JP, McGlave PB, Schiller G, Gale RP, Rowlings PA, Horowitz MM.
    Blood; 2000 Jan 15; 95(2):410-5. PubMed ID: 10627443
    [Abstract] [Full Text] [Related]

  • 9. Alpha-interferon in chronic myelogenous leukaemia.
    Kumar L, Gulati SC.
    Lancet; 1995 Oct 14; 346(8981):984-6. PubMed ID: 7475589
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation: the case for giving interferon.
    Steegmann JL, Casado F, Granados E, Fernández Rañada JM.
    Blood; 1998 Apr 01; 91(7):2617-8. PubMed ID: 9516164
    [No Abstract] [Full Text] [Related]

  • 11. Bone marrow transplantation for chronic myelogenous leukemia: clinical outcomes.
    Enright H, Davies S, McGlave P.
    Clin Transpl; 1994 Apr 01; ():283-93. PubMed ID: 7547549
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Kantarjian HM, Talpaz M.
    Semin Oncol; 1994 Dec 01; 21(6 Suppl 14):8-13. PubMed ID: 7992099
    [Abstract] [Full Text] [Related]

  • 14. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
    Zuffa E, Bandini G, Bonini A, Santucci MA, Martinelli G, Rosti G, Testoni N, Zaccaria A, Tura S.
    Haematologica; 1998 Mar 01; 83(3):231-6. PubMed ID: 9573677
    [Abstract] [Full Text] [Related]

  • 15. Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure.
    Hehlmann R, Hochhaus A, Kolb HJ, Hasford J, Gratwohl A, Heimpel H, Siegert W, Finke J, Ehninger G, Holler E, Berger U, Pfirrmann M, Muth A, Zander A, Fauser AA, Heyll A, Nerl C, Hossfeld DK, Löffler H, Pralle H, Queisser W, Tobler A.
    Blood; 1999 Dec 01; 94(11):3668-77. PubMed ID: 10572078
    [Abstract] [Full Text] [Related]

  • 16. [Interferon-alpha therapy in chronic myelogenous leukemia].
    Ohnishi K.
    Rinsho Ketsueki; 2000 Apr 01; 41(4):275-9. PubMed ID: 10846454
    [No Abstract] [Full Text] [Related]

  • 17. Interferon alfa-2a.
    Williams CD, Linch DC.
    Br J Hosp Med; 2000 Apr 01; 57(9):436-9. PubMed ID: 9274677
    [Abstract] [Full Text] [Related]

  • 18. Rapidly progressive renal graft failure associated with interferon-alpha treatment in a patient with chronic myelogenous leukemia.
    Bren A, Kandus A, Ferluga D.
    Clin Nephrol; 1998 Oct 01; 50(4):266-7. PubMed ID: 9799075
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. NCCN Practice Guidelines for Chronic Myelogenous Leukemia.
    Berman E, Clift RA, Copelan EA, Emanuel PD, Erba HP, Glenn MJ, Greenberg PL, Jones RJ, O'Brien S, Saba HI, Schilder R, Snyder DS, Soiffer RJ, Tallman MS, Wetzler M, Ravandi-Kashani F, Kantarjian H, Talpaz M, National Comprehensive Cancer Network.
    Oncology (Williston Park); 2000 Nov 01; 14(11A):229-40. PubMed ID: 11195415
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.